Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 28, 2024; 30(12): 1714-1726
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1714
Table 5 Univariate and multivariate analysis of disease-free survival
Risk factorsUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Age (yr)1.031 (1.025-1.038)< 0.01a1.027 (1.020-1.033)< 0.01a
Sex (female/male)0.861 (0.730-1.015)0.058
BMI (kg/m2)0.975 (0.953-0.997)0.029a1.003 (0.981-1.026)0.784
T2DM (yes/no)1.127 (0.911-1.396)0.271
Tumor site (colon/ rectum)1.126 (0.975-1.300)0.107
Tumor stage (IV/III/II/I)2.120 (1.926-2.334)< 0.01a2.093 (1.900-2.307)< 0.01a
Smoking (yes/no)1.093 (0.944-1.267)0.234
Drinking (yes/no)1.104 (0.946-1.288)0.208
Hypertension (yes/no)1.036 (0.879-1.220)0.676
CHD (yes/no)1.281 (0.917-1.791)0.147
Tumor size (≥ 5 cm/< 5 cm)1.363 (1.180-1.574)< 0.01a1.115 (0.962-1.294)0.149
RDW (lower/higher)0.713 (0.616-0.824)< 0.01a0.920 (0.783-1.080)0.308
Hematocrit (lower/higher)1.509 (1.304-1.747)< 0.01a1.194 (1.013-1.408)0.035a
Overall complications (yes/no)1.705 (1.463-1.987)< 0.01a1.510 (1.293-1.763)< 0.01a